Empower Clinics Inc| Business Overview| Stock Price



Empower Clinics Inc is one of the best operators and regulators of medical fitness and wealth centers in the United States and Canada. Empower Clinics Inc was founded in 2015. The head office of this company is located in Vancouver, Canada. Their work is based on integrated healthcare regarding body and mind wellness. The vision of this company is to deal with both prevention and problems and to treat worldwide patients with conventional and alternative medicines.

Moreover, the company is based on well-organized members loyal to fulfilling the organizational goals. They all are dedicated to performing their tasks with high efficiency. Besides covering the healthcare, finance, technology, and capital markets, Empower Clinics holds excellent and diverse leadership. Therefore, this international firm deals with more than 200,000 patients in the United States and Canada.

Business Overview:

Empower Clinics ethically runs its business and covers the market core segmentation with a massive offering of EPWCF Stock. This company is expanding rapidly and growing its business by making success. Hence, the Empower Clinic is growing forward and engaged in a rollout strategy focusing on maintaining its growth in the UK and Canada.

Besides this, it contributes a lot to the economy of commercial and industrial sectors. It is changing the shape of medical and technological services by focusing on the patient first integrated health and fitness. Hence, by fulfilling all the needs and requirements of patients, this company aims to provide quality products and services with the vigilance of paramedical expert staff.

EPWCF Stock:

If you are considering investing in the EPWCF Stock and want to explore more about it, then you are at the best place. So, continue reading this masterpiece and get all the desired information regarding the outstanding stock of Empower Clinics Inc.

Current Stock Prices:

The current value of EPWFC Stock is 0.066 US dollars. In the recent Five days, the stock's price was 0.078 US dollars on July 1, 2022. And it was 0.070 US dollars on July 7, 2022.


Stock Volatility Or Stability:

The EPWCF Stock is highly stable with a rate of 55.80 US Dollars on September 1, 2000. The price was 52.70 US dollars on September 22, 2000. Moreover, some other dates where the stock is highly stable are given below:

  • · October 6, 2000

  • · September 15, 2000

  • · August 18, 2000

  • · August 4, 2000

Maximum Stock Price In the Last Five Years:

The maximum price of EPWCF in the last five years was 55.80 US Dollars on September 1, 2000.

Minimum Stock Price In The Last Five Years:

The last five years' minimum stock price was 0.090 US dollars on April 29, 2022.

Financial Statements Analysis

By looking at the financial growth of Empower clinics, you will learn more about this company's earnings, revenues, and assets. Hence, the economic analysis of any company allows you to know about the financial conditions and achievements regarding all the business activities.

Therefore, the financial statement analysis of this company is given below. Let's have a look at that.

Earnings:

This company's earnings have declined by 69.1% over the past five years. There is a rapid decrease in the earnings graph. The payments are 4.302 Million US Dollars in 2020 and 17.066 Million US dollars in 2021.

Revenues:

The revenues declined from the year 2017 to 20221. Therefore, the graph shows a sudden decrease. Hence, the payments at the end of the year 2021 are 38.669 Million US dollars, while the revenues are 1.592 Million US Dollars.

Debt To Equity Ratio:

The debt to equity ratio increased to 61.2% at the end of 2021, and the obligation to equity ratio was -63.5% in 2017. Moreover, the value of equity ratio is 2.913 Million US Dollars in the year 2021.

Liabilities:

All the short-term liabilities range from 3.67 Million US Dollars, and the long-term penalties range to 5.54 Million US dollars.

Assets:

All the long-term assets are worth 8.36 Million US dollars, which exceeds the long-term liabilities. Moreover, all the short-term investments worth 3.7 Million US dollars cover the short-term liabilities.


Comments

New comments are not allowed.

Popular posts from this blog

Trillium Gold Mines Inc- Overview

Image
TGLDF- Trillium Gold Mines Inc head office is based in Canada. The main activity of this company is to find new mineral assets on the earth. Currently, the company is working on gold exploration in the Red Lake. The company is involved in several projects, some of them are Newman Todd, Red Lake West, Shining Tree, copper lode west etc.  Trillium Gold Mines Inc-  TGLDF  is showing consistent growth in revenues for the last few years. The company started its operations on November 3, 2005, the company's head office is in Vancouver.  The current share price on 27 May 2022 is 0.31 (Canadian dollars).  On 8th March 2022, the company offered 1,25,0000  incentive stock to Its management ( include of directors and other employees). The offer also includes the option to buy a common share by its management.  On March 2, 2022. Trillium Gold Mines Inc announced the closing of c$7.5million brokered private placement. On April 26, 2022. Trillium Gold Mines
Read more

LGIQ Busienss Overview

Image
LGIQ Busienss Overview LGIQ started its operations on 4 November 2022 and the company head office is in NewYork, United States. The company is involved in digital marketing and lead generation solutions for its customers.  The company business has two-part: one is digital marketing and the other is consumer marketplace. The company provides e-commerce solutions to Europe, Asia and America. The company data management tools and funnels help you find the right business consumers. The company's target customers are small and medium-sized businesses.  Brent Suen is the Chief Executive Officer and the John MacNeil is the Chief Operating Officer. Approximately more than 37 employees are working in LOGIQ.  LGIQ Stock LGIQ Stock is currently (13 June 2022) selling at 0.39 US Dollars. For the last five years, the stock price has been showing a decrease in the price. The stock was trading at 88.54 US dollars on 2 January 2018, and after this, the stock price for company shares is consistent
Read more

Interpace Biosciences Completes Its Pharma Services Business Sale to Flagship Biosciences, Inc.

Image
The Company announces the complete sale of the pharma services business which could impact the IDXG Stock . For more information regarding the Company's business, visit OTC Wiki.  Interpace Biosciences Inc is a leading company that specializes in enabling personalized medicinal products. This Company has closed a definitive asset purchase agreement under the Flagship of Biosciences Inc. It has acquired the Company's pharma services business.  The Company will also use the proceeds from the transaction for working capital requirements and investments to help drive the growth of its molecular diagnostics business. The president and CEO of the Company also announced that with the completion of the multiple transactions, we expect the Company to make progress. Moreover, the company's driven ash flow will focus on molecular diagnostics that the Company is offering the best in class solutions and other diagnostic insights. Besides providing the IDXG Stock, the Company determines
Read more